Esperion Therapeutics (ESPR)
(Delayed Data from NSDQ)
$2.36 USD
+0.02 (0.85%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $2.36 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | 0.34 |
Last EPS Surprise | 525.00% |
ABR | 2.00 |
Earnings ESP
|
93.82% |
---|---|
Current Year | 0.03 |
Next Year | 0.31 |
EPS (TTM) | -0.99 |
P/E (F1) | 83.29 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 46.23M | 63.67M | 322.28M | 492.66M |
# of Estimates | 5 | 5 | 5 | 4 |
High Estimate | 60.00M | 76.84M | 384.50M | 664.80M |
Low Estimate | 37.80M | 47.29M | 282.37M | 404.14M |
Year ago Sales | 25.79M | 33.97M | 116.33M | 322.28M |
Year over Year Growth Est. | 79.26% | 87.43% | 177.03% | 52.87% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.11 | 0.03 | 0.31 |
# of Estimates | 6 | 5 | 6 | 5 |
Most Recent Consensus | -0.23 | -0.14 | -0.23 | -0.01 |
High Estimate | -0.01 | -0.05 | 0.60 | 1.18 |
Low Estimate | -0.25 | -0.20 | -0.23 | -0.21 |
Year ago EPS | -0.46 | -0.37 | -2.03 | 0.03 |
Year over Year Growth Est. | 65.22% | 70.27% | 101.48% | 945.56% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 3 | 3 | 5 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.11 | 0.03 | 0.31 |
7 Days Ago | -0.18 | -0.11 | -0.05 | 0.33 |
30 Days Ago | -0.18 | -0.11 | -0.05 | 0.32 |
60 Days Ago | -0.23 | -0.15 | -0.55 | 0.30 |
90 Days Ago | -0.23 | -0.15 | -0.55 | 0.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.01 | -0.11 | 0.60 | -0.11 |
Zacks Consensus Estimate | -0.16 | -0.11 | 0.03 | 0.31 |
Earnings ESP | 93.82% | 0.00% | 2,017.67% | -135.26% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.34 | -0.50 | -0.37 | -0.46 | NA |
Estimate | -0.08 | -0.53 | -0.42 | -0.63 | NA |
Difference | 0.42 | 0.03 | 0.05 | 0.17 | 0.17 |
Surprise | 525.00% | 5.66% | 11.90% | 26.98% | 142.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more